CA Patent

CA3185118A1 — Liposome formulations

Assigned to Thermosome GmbH · Expires 2022-01-13 · 4y expired

What this patent protects

The current invention provides thermosensitive liposomes and formulations thereof preferably for treating, ameliorating, delaying, curing and/or preventing cancer.

USPTO Abstract

The current invention provides thermosensitive liposomes and formulations thereof preferably for treating, ameliorating, delaying, curing and/or preventing cancer.

Drugs covered by this patent

Patent Metadata

Patent number
CA3185118A1
Jurisdiction
CA
Classification
—
Expires
2022-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Thermosome GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.